Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Trillium Therapeutics to be Acquired by Pfizer for $18.50 per Share, Implying an Equity Value of $2.26B

Author: Luke J Jacobi | August 23, 2021 06:46am

Posted In: PFE TRIL TSX:TRIL